Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer

Clinical Oncology

Volumn 19, Issue 1, 2007, Pages 83-86

  Hyer, S ^a   Kong, A ^a   Pratt, B ^a   Harmer, C ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Radioiodine; salivary gland; thyroid cancer

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; PAIN; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SALIVARY GLAND DISEASE; SIALOADENITIS; SWELLING; THYROID CANCER; THYROIDECTOMY; TREATMENT DURATION; XEROSTOMIA;

ADENOMA; ADENOMA, OXYPHILIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALIVARY GLANDS; THYROID NEOPLASMS; TREATMENT OUTCOME; XEROSTOMIA;

EID: 33846031578     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.11.005     Document Type: Article

References (10)

1. Allweiss P., Braunstein G.D., Katz A., and Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 25 (1984) 755-758
2. Alexander C., Bader J.B., Schaefer A., Finke C., and Kirsh C.M. Intermediate and long term side-effects of high dose radioiodine therapy for thyroid carcinoma. J Nucl Med 39 (1998) 1551-1554
3. Caglar M., Tuncel M., and Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med 27 (2002) 767-771
4. Nakada K., Ishibashi T., Takei T., et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?. J Nucl Med 46 (2005) 261-266
5. Malpani B.L., Samuel A.M., and Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys 35 (1996) 535-540
6. Mandel S.J., and Mandel L. Radioactive iodine and the salivary glands. Thyroid 13 (2003) 265-271
7. Mandel S.J., and Mandel L. Persistent sialadenitis after radioactive iodine therapy: report of two cases. J Oral Maxillofac Surg 57 (1999) 738-741
8. Lin W.Y., Shen Y.Y., and Wang S.J. Short-term hazards of low dose radioiodine ablation therapy in post-surgical thyroid cancer patients. Clin Nucl Med 21 (1996) 780-782
9. Bohuslavizki K.H., Brenner W., Klutmann S., et al. Radioprotection of salivary glands by amifistone in high dose radioiodine therapy. J Nucl Med 39 (1998) 1237-1242
10. http://www.controlled-trials.com/ISRCTN56078540